These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 12692689

  • 1. Positron emission tomography in the management of lymphomas: a summary.
    O'Doherty MJ, Hoskin PJ.
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S128-30. PubMed ID: 12692689
    [No Abstract] [Full Text] [Related]

  • 2. Value of positron emission tomography in diagnosing subcutaneous panniculitis-like T-cell lymphoma.
    Bennani-Baiti B, Yadav S, Flynt L, Bennani-Baiti N.
    J Clin Oncol; 2015 Apr 01; 33(10):1216-7. PubMed ID: 25691676
    [No Abstract] [Full Text] [Related]

  • 3. FDG PET in the management of lymphoma: a clinical perspective.
    Hoskin PJ.
    Eur J Nucl Med Mol Imaging; 2002 Apr 01; 29(4):449-51. PubMed ID: 11914880
    [No Abstract] [Full Text] [Related]

  • 4. Do not abandon the bone marrow biopsy yet in diffuse large B-cell lymphoma.
    Adams HJ, Kwee TC.
    J Clin Oncol; 2015 Apr 01; 33(10):1217. PubMed ID: 25691675
    [No Abstract] [Full Text] [Related]

  • 5. Positron emission tomography with [(18)F]FDG for therapy response monitoring in lymphoma patients.
    Spaepen K, Stroobants S, Verhoef G, Mortelmans L.
    Eur J Nucl Med Mol Imaging; 2003 Jun 01; 30 Suppl 1():S97-105. PubMed ID: 12709831
    [Abstract] [Full Text] [Related]

  • 6. Fluorine-18 fluorodeoxyglucose positron emission tomography for lymphoma: incorporating new technology into clinical care.
    Kaplan LD.
    Am J Med; 2002 Mar 01; 112(4):320-1. PubMed ID: 11893374
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
    Specht L.
    Semin Radiat Oncol; 2007 Jul 01; 17(3):190-7. PubMed ID: 17591566
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in the treatment of Hodgkin's disease and malignant non-Hodgkin's lymphoma].
    Bourguet P, Groupe de Travail SOR.
    Bull Cancer; 2003 Feb 01; 90 Spec No():S88-95. PubMed ID: 12739340
    [No Abstract] [Full Text] [Related]

  • 11. [Value of positron emission tomography in treatment of lymphoma patients].
    Kuwert T.
    Strahlenther Onkol; 2001 Mar 01; 177(3):160-1. PubMed ID: 11285774
    [No Abstract] [Full Text] [Related]

  • 12. New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.
    Cheson BD.
    Radiol Clin North Am; 2008 Mar 01; 46(2):213-23, vii. PubMed ID: 18619377
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment.
    Bar-Shalom R, Mor M, Yefremov N, Goldsmith SJ.
    Semin Nucl Med; 2001 Jul 01; 31(3):177-90. PubMed ID: 11430525
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. FDG positron emission tomography in lymphoma.
    Tecnologica MAP Suppl; 2000 Jan 01; ():9-10. PubMed ID: 10848116
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. PET imaging in lymphoma.
    Hutchings M.
    Expert Rev Hematol; 2009 Jun 01; 2(3):261-76. PubMed ID: 21082968
    [Abstract] [Full Text] [Related]

  • 20. Assessment of Lymphoma Therapy Using (18)F-FDG PET.
    Lowe VJ, Wiseman GA.
    J Nucl Med; 2002 Aug 01; 43(8):1028-30. PubMed ID: 12163627
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.